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Abstract
The occurrence of nucleic acid cross contamination in the laboratory resulting in false posi-
tive results of diagnostic samples is seriously problematic. Despite precautions to minimize
or even avoid nucleic acid cross contaminations, it may appear anyway. Until now, no stan-
dardized strategy is available to evaluate the efficacy of commercially offered decontamina-
tion reagents. Therefore, a protocol for the reliable determination of nucleic acid
decontamination efficacy using highly standardized solution and surface tests was estab-
lished and validated. All tested sodium hypochlorite-based reagents proved to be highly effi-
cient in nucleic acid decontamination even after short reaction times. For DNA Away, a
sodium hydroxide-based decontamination product, dose- and time-dependent effective-
ness was ascertained. For two other commercial decontamination reagents, the phosphoric
acid-based DNA Remover and the non-enzymatic reagent DNA-ExitusPlus™ IF, no reduc-
tion of amplifiable DNA/RNA was observed. In conclusion, a simple test procedure for eval-
uation of the elimination efficacy of decontamination reagents against amplifiable nucleic
acid is presented.
Introduction
In recent years, polymerase chain reaction (PCR) has been used frequently for various applica-
tions in molecular biology, inter alia for the diagnosis of infectious agents [1]. Especially when
it comes to diagnostics the minimization of nucleic acid cross contaminations is of utmost
importance. Despite precautions to avoid contaminations, such as spatial separation of PCR
preparation from product handling, ultraviolet (UV) irradiation or uracil-N-glycosylase treat-
ment [2–4], nucleic acid cross contaminations may occur in molecular diagnostic laboratories
anyway. The crucial question in these situations is: Which reagents are most efficient in decon-
taminating nucleic acid? Recently, Champlot et al. [5] have established a decontamination
strategy for PCR reagents, but a standardized protocol for assessment of the efficacy of
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decontamination reagents in the molecular diagnostic laboratory is missing. Standardized
national and international guidelines are available for determination of the efficacy of disinfec-
tants [6, 7], while for the evaluation of decontamination reagents such specifications are miss-
ing. In the present study the efficacy of four commercial nucleic acid decontamination reagents
used in molecular laboratories was compared with a hypochlorite-containing domestic clean-
ing agent and a freshly prepared 1% sodium hypochlorite solution as reference substance.
Decontamination is defined as degradation, denaturation or inactivation of amplification of
nucleic acids. Targets for the comparative analyses were short PCR amplicons (target DNA)
and in vitro transcripts (target RNA) as the most relevant cross contaminants in a routine PCR
lab. In this context the reduction of amplifiable target DNA or RNA by the different decontam-
ination reagents was investigated independently of the principle of operation. Based on the dis-
infection guideline of the German Veterinary Society [8] and in compliance with European
norms for suspension tests [9] and surface tests [10] we propose a test strategy for the evalua-
tion of nucleic acid decontamination reagents. The recommended test procedure might be
helpful for molecular diagnostic laboratories to verify the efficacy of decontamination reagents.
Materials and Methods
Generation of target nucleic acids (`cross contamination`)
For generation of both target nucleic acids (DNA-amplicon and in-vitro RNA) used in this
study the pGEM-EGFP2rev plasmid, established by Hoffmann et al. [11] (containing a 712 bp
fragment of the EGFP gene), was utilized.
The DNA-amplicon (named target DNA) was produced by amplification of a 712 bp frag-
ment of the EGFP gene from the pGEM-EGFP2rev plasmid using the QuantiTect Multiplex
PCR NoRox Kit (Qiagen, Hilden, Germany). For one reaction 5.5 μL RNase-free water, 12.5 μL
2x QuantiTect Multiplex PCRMaster Mix, 1.0 μL of primers EGFP-15-F and EGFP-10-R
(10 μM) [11] each, as well as 5.0 μL pGEM-EGFP2rev plasmid (2x 109 copies per μL) were
mixed. The following thermal program was applied: 1 cycle of 95°C for 15 min, followed by 45
cycles of 95°C for 60 s, 60°C for 30 s, and 72°C for 30 s. PCR products were analyzed on a 1.5%
agarose gel and purified using the QIAquick Gel Extraction Kit (Qiagen) according to the man-
ufacturer's instructions. The exact number of DNA molecules was calculated as described [12]
and adjusted to a concentration of 2x 107 copies per μL. Dilution of the target DNA was per-
formed in phosphate buffered saline (PBS).
For generation of the target RNA, the pGEM-EGFP2rev plasmid was linearized using the
restriction enzyme NcoI and agarose gel was purified as described by Hoffmann et al. [11]. The
resulting plasmid DNA was in vitro transcribed using the RiboMAX Large Scale RNA Produc-
tion Systems (Promega, Mannheim, Germany). A DNase I digestion was performed subse-
quently using the SP6/T7 Transcription Kit (Roche Diagnostics, Mannheim, Germany)
according to the manufacturer’s instructions. During purification of the in vitro transcribed
RNA using the RNeasy Mini Kit (Qiagen) a second on-column DNase I digestion according to
the manufacturer’s recommendations was implemented. The exact number of RNA molecules
was calculated as described [12] and adjusted to a concentration of 2x 107 copies per μL. The
target RNA was diluted in RNase free water.
Decontamination reagents
As reference substance a 1% sodium hypochlorite solution was prepared from a 10–15% stock
solution (Sigma-Aldrich Chemie GmbH, Steinheim, Germany). Relevant data regarding the
applied commercial decontamination reagents are summarized in Table 1. All reagents were
used before the date of expiry. Dilutions of the decontamination reagents were prepared freshly
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in 1x PBS (testing of target DNA) or RNase free water (testing of target RNA) before applica-
tion. Appropriate storage conditions and storage life were considered for the reagents tested.
Solution test
Suspension tests (based on Chemical disinfectants and antiseptics—Quantitative suspension test
for the evaluation of bactericidal activity of chemical disinfectants and antiseptics used in veteri-
nary area—Test method and requirements (DIN EN 1656) [9]) were performed as preliminary
approach to gain basic information and to facilitate comparison of the efficacy of the different
decontamination reagents. Therefore, 10 μL of the respective reagent or a dilution of the reagent
(indicated in Table 1) were filled into a well of MagNA Pure LC Processing Cartridges (Roche
Diagnostics, Mannheim, Germany) in triplicates. Furthermore, wells with 10 μL of 1x PBS or
RNase free water were implemented as no-reagent-controls and delivered the reference Cq val-
ues for the target DNA and RNA of each experiment. To start the decontamination procedure,
10 μL of the target nucleic acid were added to the well; the solution was mixed thoroughly and
spun down. Reactions of target DNA or RNA with the decontamination reagents were stopped
after 2 or 10 min. For this purpose, 180 μL 1x PBS and 200 μL lysis buffer AL (MagAttract Virus
Mini M48 Kit from Qiagen) were added to each well together with 10 μL internal control nucleic
acid, i.e. T7-DNA (20–50 pg; GeneOn, Ludwigshafen, Germany) or MS2-RNA (80 pg; Roche
Diagnostics) to ensure proper RNA/DNA-extraction and the performance of real-time (reverse
transcriptase (RT-))-PCR. The solution was mixed thoroughly by shaking, spun down and then
incubated for 15 min at room temperature. After incubation, the content of each well was trans-
ferred to a Thermo 96-well deep well plate (Thermo Scientific, Braunschweig, Germany) and
nucleic acid was extracted using the MagAttract Virus Mini M48 Kit (Qiagen) according to the
manufacturer’s instructions on the King Fisher 96 Flex (Thermo Scientific) platform. All tests
were performed as triplicates twice on two independent days. Moreover, an undiluted aliquot of
each tested decontamination reagent was kept un-protected from light for two weeks at room
temperature and was then tested again with the target DNA to investigate a light-induced loss of
efficacy. All incubations were performed at room temperature (21±1°C).
Surface test
Surface tests resembling laboratory conditions (based on the procedure described in Chemical
disinfectants and antiseptics—Quantitative surface test for the evaluation of bactericidal
Table 1. Set of decontamination reagents applied in this study.





Hypochlorite (10–15%) Sigma-Aldrich Chemie GmbH, Steinheim,
Germany
STBD5198V - sodium hypochlorite 1% solution, 1:4,
1:16
DNA Away Carl Roth GmbH & Co. KG, Karlsruhe,
Germany
12441062 1 sodium hydroxide undil., 1:4, 1:16
DNA Remover Minerva Biolabs GmbH, Berlin, Germany 152D1082 1 phosphoric acid undil., 1:4, 1:16
DNA-ExitusPlus™ IF AppliChem GmbH, Darmstadt, Germany 3P002304 10 non enzymatic undil., 1:4, 1:16
LTK-008 BioDelta GmbH, Löhne, Germany - 5–10 sodium hypochlorite undil., 1:4, 1:16
Sagrotan Schimmel-
frei*
Reckitt Benckiser, Mannheim, Germany - 10–15 sodium hypochlorite undil., 1:4, 1:16
#: recommended by the supplier
*: identical with Complete Clean Mould & Mildew Remover from DETTOL (Reckitt Benckiser; Berkshire, UK)
-: no information available; undil.: undiluted reagent
doi:10.1371/journal.pone.0159274.t001
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activity of chemical disinfectants and antiseptics used in the veterinary area on non-porous
surfaces without mechanical action—Test method and requirements (DIN EN 14349) [10])
were performed by drying 10 μL target nucleic acid in MagNA Pure LC Processing Cartridges
(Roche Diagnostics) in triplicates overnight at room temperature in a laminar hood. After-
wards 50 μL of the respective decontamination reagent, reagent dilution or no-reagent-control
(see solution test) were added and incubated for 2 or 10 min. Decontamination reactions were
stopped by adding 150 μL 1x PBS and 200 μL lysis buffer AL (MagAttract Virus Mini M48 Kit
from Qiagen). Also here 10 μL internal control nucleic acid (T7-DNA or MS2-RNA) were
added to each well and the nucleic acid was extracted as described above.
Real-time PCR
For amplification and detection of the respective target (`cross contamination`) and the inter-
nal control nucleic acid, the Takyon No ROX Probe Mastermix Kit (Eurogentec, Köln, Ger-
many) was used. Briefly, for amplification of the target DNA and the internal DNA control
1.0 μL RNase-free water, 5.0 μL Takyon MasterMix, 1.0 μL EGFP-Mix1 (Table 2), 1.0 μL inter-
nal control DNA mix (Table 2) and 2.0 μL template, positive control or RNase free water for
the no template control (NTC) were used per reaction. The following thermal program was
applied: 95°C for 3 min, followed by 40 cycles of 95°C for 10 s, 57°C for 20 s and 68°C for 30 s.
For reverse transcriptase (RT-) PCR of the target RNA and the internal RNA control the Tak-
yon No ROX Probe Mastermix Kit (Eurogentec) was used in combination with the RT core kit
(Eurogentec). For one reaction 0.85 μL RNase-free water, 5.0 μL Takyon MasterMix, 0.05 μL
Euroscript RT mix, 0.1 μL RT additive, 1.0 μL EGFP-Mix1 (Table 2), 1.0 μL internal control
RNA mix (Table 2) and 2.0 μL template, positive control or RNase free water for the no tem-
plate control (NTC) were mixed. The following thermal program was applied: 1 cycle of 48°C
for 30 min and 95°C for 3 min, followed by 40 cycles of 95°C for 10 s, 57°C for 20 s and 68°C
for 30 s.
All reactions were performed as triplicates in Bio-Rad 96-well PCR plates using a CFX96
quantitative PCR system (Bio-Rad Laboratories, Hercules, USA). For each real-time PCR, a
quantification cycle number (Cq) was determined according to the PCR cycle number at which
the fluorescence of the reaction exceeds a value that is statistically higher than the background,
which is determined by the respective software associated with the system.
Table 2. Oligonucleotide sequences and composition of primer-probe mixes used in this study.
Detection of Assay Primer/Probe Sequence (5'-3') Concentration [μM]
EGFP-Mix1 EGFP1-F GAC CAC TAC CAG CAG AAC AC 2.5
target RNA and DNA (amplify a 133 bp fragment) EGFP2-R GAA CTC CAG CAG GAC CAT G 2.5
EGFP-Probe 1 FAM- AGC ACC CAG TCC GCC CTG AGC A -BHQ1 1.25
T7-DNA-Mix6 T7-14510-F GCG GTC TTA TTG TGT TCC AC 7.5
internal control DNA (amplify a 86 bp fragment) T7-14595-R GAA CTC TCG GTT CAA TTG CAA C 7.5
T7-14535-HEX HEX- TCA CAA GTA TGA CGT TCC TGC ATT GAC -BHQ1 1.88
MS2-RNA-Mix10 MS2-3167-F GCT ACT CGC GGA TAC CCG 7.5
internal control RNA (amplify a 123 bp fragment) MS2-3289-R ACT TCA CCT CCA GTA TGG AAC 7.5
MS2-TM3-HEX HEX- ACC TCG GGT TTC CGT CTT GCT CGT -BHQ1 1.88
FAM: 6-carboxyﬂuorescein; HEX: 50-hexachloroﬂuorescein; BHQ1: black hole quencher 1.
doi:10.1371/journal.pone.0159274.t002
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Results and Discussion
To assess the efficacy of five commercial nucleic acid decontamination reagents used in the lab-
oratory as well as a domestic cleaning agent (Table 1) a double-check strategy, composed of a
solution test and a surface test, was performed (Tables 3 and 4). As a first step, the solution test
Table 3. Evaluation of the nucleic acid decontamination efficacy by the solution test protocol.
DNA-amplicon in-vitro RNA
Reaction time 2 min 10 min 2 min 10 min
Reagent Dilution mean Cq ± SD mean Cq ± SD mean Cq ± SD mean Cq ± SD
no reagent undil. 17.8 0.40 17.5 0.25 19.1 0.11 19.6 0.49
1% Hypochl. all no Cq - no Cq - no Cq - no Cq -
undil. 35.4 0.98 no Cq - no Cq - no Cq -
DNA Away 1:4 32.2 1.30 36.9 0.68 no Cq - no Cq -
1:16 20.2 0.89 23.6 0.23 34.7 1.30 no Cq -
undil. 17.2 0.07 17.8 0.30 19.7 0.40 19.5 0.14
Remover 1:4 17.3 0.12 18.3 0.36 19.7 0.41 19.9 0.34
1:16 18.0 0.29 17.7 0.37 19.7 0.29 19.7 0.34
undil. 17.1 0.20 16.9 0.13 18.5 0.26 18.4 0.26
DNA Exitus 1:4 17.4 0.37 17.7 0.42 18.8 0.13 18.8 0.12
1:16 17.6 0.50 18.6 0.77 19.1 0.11 19.1 0.18
LTK-008 all no Cq - no Cq - no Cq - no Cq -
Sagrotan all no Cq - no Cq - no Cq - no Cq -
no reagent: no-reagent-control; 1% Hypochl.: 1% hypochlorite solution (reference substance); Remover: DNA Remover; DNA Exitus: DNA-ExitusPlus™ IF;
Sagrotan: Sagrotan Schimmel-frei; undil.: undiluted; all: no Cq for all dilution values; mean Cq: mean Cq value from 6 replicates; SD: standard deviation; no
Cq: no Cq-value detected; -: no value available.
doi:10.1371/journal.pone.0159274.t003
Table 4. Evaluation of the nucleic acid decontamination efficacy by the surface test protocol.
DNA-amplicon in-vitro RNA
Reaction time 2 min 10 min 2 min 10 min
Reagent Dilution mean Cq ± SD mean Cq ± SD mean Cq ± SD mean Cq ± SD
no reagent undil. 24.0 0.29 23.2 0.58 21.2 0.34 21.3 1.28
1% Hypochl. all no Cq - no Cq - no Cq - no Cq -
undil. 36.2 0.64 36.1 0.44 no Cq - no Cq -
DNA Away 1:4 32.4 0.29 33.7 0.38 no Cq - no Cq -
1:16 30.8 0.66 31.3 0.32 no Cq - no Cq -
undil. 23.6 0.67 23.6 0.65 22.5 1.49 21.9 1.17
Remover 1:4 24.8 0.57 24.2 0.58 21.4 0.65 21.7 0.36
1:16 24.2 0.46 23.8 0.50 22.1 0.86 21.0 0.66
undil. 24.3 0.39 24.2 0.43 21.3 0.51 21.4 0.91
DNA Exitus 1:4 23.1 0.39 22.9 0.58 20.5 0.95 20.6 0.40
1:16 23.2 1.11 23.9 0.81 21.5 1.44 21.4 0.67
LTK-008 all no Cq - no Cq - no Cq - no Cq -
Sagrotan all no Cq - no Cq - no Cq - no Cq -
no reagent: no-reagent-control; 1% Hypochl.: 1% hypochlorite solution (reference substance); Remover: DNA Remover; DNA Exitus: DNA-ExitusPlus™ IF;
Sagrotan: Sagrotan Schimmel-frei; undil.: undiluted; all: no Cq for all dilution values; mean Cq: mean Cq value from 6 replicates; SD: standard deviation; no
Cq: no Cq-value detected; -: no value available.
doi:10.1371/journal.pone.0159274.t004
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was established to enable a highly standardized comparison [6] of the different products. In
this approach equal volumes of the decontamination reagent and the target nucleic acid (i.e.
DNA-amplicon or in-vitro RNA) were mixed and incubated for 2 or 10 min, respectively. The
reaction was stopped by adding PBS and the lysis buffer intended from the nucleic acid extrac-
tion kit. The capability of these combined reagents to stop the reaction was confirmed in pre-
liminary tests (data not shown). Nucleic acid was extracted and amplified by real-time (RT-)
PCR. Negative effects of the different decontamination reagents regarding the inhibition-free
nucleic acid extraction and real-time (RT-) PCR amplification were excluded by integration of
internal process controls (T7-DNA and MS2-RNA).
After just a short treatment (2 min) with the reference substance (1% hypochlorite solution,
Sigma-Aldrich Chemie) or with other hypochlorite-based reagents, i.e. LTK-008 (BioDelta)
and Sagrotan Schimmel-frei (Reckitt Benckiser), neither target DNA nor target RNA were
amplifiable by (RT-) PCR (no Cq) for all tested decontamination reagent dilutions (Table 3). A
hypochlorite solution was used as reference substance because it is easy to prepare, cheap and
widely used in molecular laboratories [13, 14]. Furthermore, Prince and Andrus [14] demon-
strated its high decontamination efficacy. In our approach, all tested hypochlorite-based prod-
ucts, including the domestic cleaning agent, seem to be highly efficient. In contrast, the
phosphoric acid-based DNA Remover (Minerva Biolabs, Berlin, Germany) and the non-enzy-
matic reagent DNA-ExitusPlus™ IF (AppliChem, Darmstadt, Germany) did not show any
reduction of amplifiable nucleic acid. Even after a 10 min treatment with the undiluted prod-
ucts, detected Cq values were similar to those measured from the no-reagent-control.
The sodium hydroxide-based DNA Away reagent (Carl Roth, Karlsruhe, Germany) dis-
played a dose-dependent efficacy. Incubation for 2 min with DNA Away led to partial elimina-
tion of the target DNA, indicated by a prominent increase of the Cq values in comparison to
the no-reagent-control (Table 3). The decontamination efficacy increased from the 1:16 dilu-
tion up to the undiluted reagent (1:16<1:4<undil.). After a 10 min treatment using undiluted
DNA Away, no target DNA was detectable anymore. Furthermore, DNA Away exhibited an
improved performance of target RNA elimination. No RNA was detectable after a 2 min incu-
bation using the undiluted product and the 1:4 dilution. After incubation for 10 min, no RNA
target was detectable at all.
Finally, undiluted aliquots of all decontamination reagents as well as the reference substance
were tested again after a 14-day storage period at room temperature, un-protected from light.
Despite these non-appropriate storage conditions, differences regarding the decontamination
performance for DNA were not observed (Table 5). Especially, the light sensitive hypochlorite-
based reagents remained highly efficient.
As a second step, the more practice-orientated surface test was analyzed. In this approach
actually 50 μL reagent were applied to the dried up target nucleic acid to ensure complete cov-
erage of the dried `contamination`. Again incubation times of 2 min or 10 min, respectively,
were tested and the nucleic acid decontamination efficacy was analyzed by real-time PCR.
Analogous to the solution test, the reference substance, LTK-008 and Sagrotan Schimmel-frei
eliminated amplifiable nucleic acid, DNA as well as RNA, in every tested dilution after a 2 min
treatment (Table 4). DNA Remover and DNA-ExitusPlus™ IF again were ineffective yielding
similar Cq values as the no-reagent-control. With regard to the surface test, DNA Away was
not as effective in eliminating the DNA target as in the solution test (Tables 3 and 4). Even
after a 10 min treatment using DNA Away, only partial dose-dependent elimination of the tar-
get DNA was observed. However, the dried up target RNA was eliminated effectively by every
tested dilution already after 2 min of incubation. Non-template controls were always negative.
In general, real-time (RT-) PCR analysis of the internal control nucleic acid (T7 DNA or
MS2 RNA) revealed no extraction failure or PCR inhibition in the analyzed reactions
Efficacy Assessment of Nucleic Acid Decontamination Reagents
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(concerning solution test and surface test), as evident by the consistent Cq values measured
from all samples (S1 and S2 Tables). Due to nucleic acid degradation during the drying process
as well as re-dissolving effects, obtained Cq values are generally increased in the surface test
compared with the solution test despite of using the same amount of starting material.
All incubation steps of DNA/ RNA and controls in the presence of decontamination reagent
were performed in Magna Pure plates to ensure optimal contact between the target and the
reagent accounted for by the V-shaped design of the wells. Due to this well design standardized
and reproducible results can be achieved even when using low volumes. The reproducibility
observed for three extractions per dilution on two independent days (n = 6 samples) resulted
in low standard deviation (SD) values (Tables 3 and 4). Moreover, the plate design makes it
easy to perform the 2 min and the 10 min incubation separately. This separation improves han-
dling during the experiment, and based on the highly reproducible real-time (RT-) PCR data as
well as the design of the experiments cross contamination is most widely excluded.
In summary, all tested hypochlorite-based reagents convinced by their high efficacy of
nucleic acid decontamination in the solution test as well as in the surface test, even after short
incubation periods. The sodium hydroxide-containing decontamination reagent showed a
dose- and time-dependent reduction of amplifiable nucleic acid. These results were similar to
results from Champlot and co-workers [5]. The authors used bleach and DNA Away for elimi-
nation of DNA contaminations from surfaces. In contrast, the decontamination reagents based
on phosphoric acid (DNA Remover) or non-enzymatic compounds (DNA-ExitusPlus™ IF) did
not reduce the load of amplifiable DNA or RNA according to our test procedure. To the best of
our knowledge, the decontaminating potential of DNA Remover and DNA-ExitusPlus™ IF
determined in comprehensive tests has not been published yet. Studies dealing with the efficacy
of DNA Remover were not found at all. Esser and co-workers (2006) [15] presented results for
the functionality of DNA Exitus™ and DNA-ExitusPlus™ IF for degradation of plasmid DNA in
a sponsored paper. Furthermore, Arena (2010) [16] compared DNA-ExitusPlus™ IF to a 10%
sodium hypochlorite solution in order to reduce human DNA on different work surfaces. This
Table 5. Effects of the storage of decontamination reagents on the DNA decontamination efficacy of the undiluted reagents.
Reaction time 2 min 10 min
Reagent Light mean Cq ± SD mean Cq ± SD
no reagent - 16.8 0.19 16.9 0.22
1% Hypochl. + no Cq - no Cq -
- no Cq - no Cq -
DNA Away + 35.5 0.19 no Cq -
- 35.6 0.09 no Cq -
Remover + 16.6 0.24 16.6 0.24
- 16.9 0.32 17.0 0.31
DNA Exitus + 17.0 0.10 17.0 0.13
- 17.3 0.16 17.0 0.17
LTK-008 + no Cq - no Cq -
- no Cq - no Cq -
Sagrotan + no Cq - no Cq -
- no Cq - no Cq -
no reagent: no-reagent-control; 1% Hypochl.: 1% hypochlorite solution (reference substance); Remover: DNA Remover; DNA Exitus: DNA-ExitusPlus™ IF;
Sagrotan: Sagrotan Schimmel-frei; mean Cq: mean Cq value from 3 replicates; SD: standard deviation; no Cq: no Cq-value detected; -: no value available;
Storage of the decontamination reagents 14 days at room temperature +: un-protected from light; -: protected from light.
doi:10.1371/journal.pone.0159274.t005
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insufficiently controlled study indicated an in-complete decontamination effect for both
reagents.
Most of the tested products are identified as harmful to human health due to irritating and/
or corrosive effects. Thus the recommended safety measures should be followed when using
these products. Only DNA-ExitusPlus™ IF is described to be not harmful to human health and
non-toxic. While the safety at work would benefit from non-harmful substances in general,
effective elimination of amplifiable RNA or DNAmolecules must be achieved to be suitable for
application as decontamination reagent.
The prevention and destroying of contaminating nucleic acids is very important for diag-
nostic and research laboratories operating with conventional and novel molecular methods.
Incorrect assumptions, based on contaminating RNA or DNA, might result in erroneous indi-
vidual diagnostic reports, but can be also the origin for the misinterpretation of established
databases. Recently, Cantalupo and co-workers (2015) [17] identified nucleic acid contamina-
tions originating from human papillomavirus 18 intrinsic to HeLa cells in non-cervical samples
of The Cancer Genome Atlas (TCGA) database and concluded that nucleic acid contamination
occurs frequently during experimentation at the bench. Therefore, the use of functional decon-
taminating reagents helps to reduce false sequence information extensively.
Surprisingly, clear differences in the elimination efficacy of the different decontamination
reagents against amplifiable nucleic acids were observed based on the presented simple test sys-
tems. It should be mentioned that very short PCR products, representing standard amplicons
of a routine diagnostic PCR lab, were amplified in the presented study and stronger decontami-
nation effects to high-molecular nucleic acids by the different non-hypochlorite reagents can-
not be excluded.
However, the aim of the presented study was to establish a standardized protocol for testing
of decontamination agents based on the disinfection guideline of the German Veterinary Soci-
ety [8] as well as the European norms for suspension [9] and surface tests [10]. This protocol is
easily applicable for the manufacturer and/or user to confirm the functionality of decontamina-
tion reagents. In addition, we recommend that manufacturers include information of ingredient
substances and decontamination capacity. In analogy to disinfection agents decontamination
reagents would benefit from the indicating an effectiveness value against standardized indicator
DNA.
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